125 related articles for article (PubMed ID: 2363094)
1. [Plasminogen deficiencies in 2 Spanish families. Response to the administration of DDAVP].
Tabernero MD; Galende J; Tomás JF; Alberca I; Estelles A; Vicente V
Sangre (Barc); 1990 Apr; 35(2):137-41. PubMed ID: 2363094
[TBL] [Abstract][Full Text] [Related]
2. Protein C deficiency--response to danazol and DDAVP.
Gonzalez R; Alberca I; Sala N; Vicente V
Thromb Haemost; 1985 Jun; 53(3):320-2. PubMed ID: 3840287
[TBL] [Abstract][Full Text] [Related]
3. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
[TBL] [Abstract][Full Text] [Related]
4. Severe thrombotic tendency associated with a type I plasminogen deficiency.
Leebeek FW; Knot EA; Ten Cate JW; Traas DW
Am J Hematol; 1989 Jan; 30(1):32-5. PubMed ID: 2491930
[TBL] [Abstract][Full Text] [Related]
5. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis.
Scharrer IM; Wohl RC; Hach V; Sinio L; Boreisha I; Robbins KC
Thromb Haemost; 1986 Jun; 55(3):396-401. PubMed ID: 2944241
[TBL] [Abstract][Full Text] [Related]
6. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
Sultan Y; Harris A; Strauch G; Venot A; De Lauture D
J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470
[TBL] [Abstract][Full Text] [Related]
7. [Disorders of fibrinolysis and thrombophilic states, risk factors and possibilities of dietary effects].
Cepelák V; Dvorák J; Vít L; Cepeláková H; Beránek V
Vnitr Lek; 1991 Jan; 37(1):13-20. PubMed ID: 2058093
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
9. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
Heijboer H; Brandjes DP; Büller HR; Sturk A; ten Cate JW
N Engl J Med; 1990 Nov; 323(22):1512-6. PubMed ID: 2146503
[TBL] [Abstract][Full Text] [Related]
10. Congenital deficiency of plasminogen and its relationship to venous thrombosis.
Hach-Wunderle V; Scharrer I; Lottenberg R
Thromb Haemost; 1988 Apr; 59(2):277-80. PubMed ID: 3388298
[TBL] [Abstract][Full Text] [Related]
11. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
Astedt B; Fagner U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
[TBL] [Abstract][Full Text] [Related]
12. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
Gladson CL; Scharrer I; Hach V; Beck KH; Griffin JH
Thromb Haemost; 1988 Feb; 59(1):18-22. PubMed ID: 2966450
[TBL] [Abstract][Full Text] [Related]
13. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.
Aoki N; Moroi M; Sakata Y; Yoshida N; Matsuda M
J Clin Invest; 1978 May; 61(5):1186-95. PubMed ID: 659588
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
15. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
Lechner K; Thaler E; Niessner H; Nowotny C; Partsch H
Wien Klin Wochenschr; 1977 Apr; 89(7):215-22. PubMed ID: 857429
[TBL] [Abstract][Full Text] [Related]
16. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
Ambruso DR; Jacobson LJ; Hathaway WE
Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
[TBL] [Abstract][Full Text] [Related]
17. Venous thrombosis and tissue plasminogen activator release deficiency: a family study.
Patrassi GM; Sartori MT; Viero ML; Boscaro M; Boeri G; Girolami A
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):231-5. PubMed ID: 1909902
[TBL] [Abstract][Full Text] [Related]
18. [Post-phlebitic leg ulcers and XYY karyotype: fibrinolysis and androgenic function tests. Apropos of 3 cases].
Bennet A; Caron P; Sie P; Louvet JP; Bazex J
Ann Dermatol Venereol; 1987; 114(9):1097-101. PubMed ID: 3434947
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P
Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807
[TBL] [Abstract][Full Text] [Related]
20. [Protein-S deficiency in young patients with thrombotic brain infarction].
Schäfer HP; von Felten A
Schweiz Med Wochenschr; 1989 Apr; 119(16):489-92. PubMed ID: 2524095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
